相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia
Hidekazu Sotoyama et al.
TRANSLATIONAL PSYCHIATRY (2021)
Working memory in schizophrenia: The role of the locus coeruleus and its relation to functional brain networks
Stefanie Suttkus et al.
BRAIN AND BEHAVIOR (2021)
Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes
Yun Jung Bae et al.
RADIOLOGY (2021)
Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia
Samuel J. Mabry et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2020)
Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance
Stefan P. Brugger et al.
BIOLOGICAL PSYCHIATRY (2020)
Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses
Kenneth Wengler et al.
NEUROIMAGE (2020)
Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis
Sean McGrath et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)
Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease
Jian Wang et al.
PARKINSONISM & RELATED DISORDERS (2019)
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Clifford M. Cassidy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes
J. Wang et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences
Verena Klyn et al.
PITUITARY (2018)
Comprehensive MRI quantification of the substantia nigra pars compacta in Parkinson's disease
H. Takahashi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
Neuromelanin in parkinsonian disorders: an update
Antonio Martin-Bastida et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease
Taku Hatano et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia Systematic Overview and Quality Appraisal of the Meta-analytic Evidence
Christoph U. Correll et al.
JAMA PSYCHIATRY (2017)
Pathway-Specific Dopamine Abnormalities in Schizophrenia
Jodi J. Weinstein et al.
BIOLOGICAL PSYCHIATRY (2017)
The search for imaging biomarkers in psychiatric disorders
Anissa Abi-Dargham et al.
NATURE MEDICINE (2016)
Detection of changes in the ventral tegmental area of patients with schizophrenia using neuromelanin-sensitive MRI
Fumio Yamashita et al.
NEUROREPORT (2016)
Appropriate selection of MRI sequences for common scenarios in clinical practice
Govind B. Chavhan
PEDIATRIC RADIOLOGY (2016)
Examining endogenous dopamine in treated schizophrenia using [11C]-(+)-PHNO positron emission tomography: A pilot study
Fernando Caravaggio et al.
CLINICA CHIMICA ACTA (2015)
Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
Gabriel Castellanos et al.
MOVEMENT DISORDERS (2015)
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients
S. Reimao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach
Xiangchuan Chen et al.
MAGNETIC RESONANCE IMAGING (2014)
Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia
Jennifer A. Hadley et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia
Yoshiyuki Watanabe et al.
PLOS ONE (2014)
Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
Ken-ichi Yamamoto et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)
Equipercentile linking of the BPRS and the PANSS
S. Leucht et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease
Kimihiro Ogisu et al.
NEURORADIOLOGY (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging
Makoto Sasaki et al.
NEURORADIOLOGY (2010)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus
Eri Shibata et al.
BIOLOGICAL PSYCHIATRY (2008)
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
Luigi Zecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
Makoto Sasaki et al.
NEUROREPORT (2006)
A systematic review of the prevalence of schizophrenia
S Saha et al.
PLOS MEDICINE (2005)
Proposal for a noradrenaline hypothesis of schizophrenia
K Yamamoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: Human midbrain dopamine neurons
CL Liang et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
L Zecca et al.
FEBS LETTERS (2002)
分享论文
